Jesús Cebrecos

Esteve (Spain) — Spain

Medicine · Health Sciences

8h-index154citations18works5.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Anesthesia and Pain Management(8), Veterinary Pharmacology and Anesthesia(8), Inflammatory mediators and NSAID effects(4), Pain Mechanisms and Treatments(3), Statistical Methods in Clinical Trials(3)

Publications18 total

Outcome Assessment in Children and Adolescents With Chronic Pain: An International Clinical Practice Survey
European Journal of Pain·2026Open Access
Adverse Reactions Following First-Dose Administration of Co-Crystal of Tramadol-Celecoxib Versus Tramadol Alone for Moderate-To-Severe Acute Pain
Pain and Therapy·2025Open Access
E‐52862—A selective sigma‐1 receptor antagonist, in peripheral neuropathic pain: Two randomized, double‐blind, phase 2 studies in patients with chronic postsurgical pain and painful diabetic neuropathy
European Journal of Pain·2024· 12 citedOpen Access
Safety of Co-Crystal of Tramadol-Celecoxib (CTC) in Patients with Acute Moderate-to-Severe Pain: Pooled Analysis of Three Phase 3 Randomized Trials
Pain and Therapy·2024· 2 citedOpen Access
Celecoxib‐tramadol co‐crystal in patients with moderate‐to‐severe pain following bunionectomy with osteotomy: Secondary analyses by baseline pain intensity and use of rescue medication of a phase 3, randomized, double‐blind, factorial, active‐ and placebo‐controlled trial
Pain Practice·2024· 2 citedOpen Access
Efficacy of Co-Crystal of Tramadol-Celecoxib (CTC) in Patients with Acute Moderate-to-Severe Pain: A Pooled Analysis of Data from Two Phase 3 Randomized Clinical Trials
Drugs in R&D·2024· 5 citedOpen Access
Co-crystal of tramadol–celecoxib (CTC) for acute moderate-to-severe pain
Current Medical Research and Opinion·2024· 15 citedOpen Access
Co-crystal of Tramadol-Celecoxib Versus Tramadol or Placebo for Acute Moderate-to-Severe Pain After Oral Surgery: Randomized, Double-Blind, Phase 3 Trial (STARDOM1)
Advances in Therapy·2024· 10 citedOpen Access
Efficacy and safety of co‐crystal of tramadol‐celecoxib (<scp>CTC</scp>) in acute moderate‐to‐severe pain after abdominal hysterectomy: A randomized, double‐blind, phase 3 trial (<scp>STARDOM2</scp>)
European Journal of Pain·2022· 18 citedOpen Access
Celecoxib‐tramadol co‐crystal in patients with moderate‐to‐severe pain following bunionectomy with osteotomy: A phase 3, randomized, double‐blind, factorial, active‐ and placebo‐controlled trial
Pain Practice·2022· 20 citedOpen Access
Involvement of Succinate Dehydrogenase (SDH) in Deceased Kidney Donors' Inflammation
Journal of the American Society of Nephrology·2021
Celecoxib-tramadol co-crystal: A Randomized 4-Way Crossover Comparative Bioavailability Study
Clinical Therapeutics·2021· 34 citedOpen Access
Pharmacokinetic Dose Proportionality Between Two Strengths (12.5 mg and 25 mg) of Doxylamine Hydrogen Succinate Film-Coated Tablets in Fasting State: A Single-Dose, Randomized, Two-Period Crossover Study in Healthy Volunteers
Drugs in R&D·2013· 9 citedOpen Access
Bioequivalence Study of 2 Orodispersible Formulations of Ondansetron 8 mg in Healthy Volunteers
Arzneimittelforschung·2012· 4 cited
Bioequivalence evaluation of two oral formulations of quetiapine fumarate in healthy volunteers
Arzneimittelforschung·2011· 1 cited
Comparative bioavailability study of triflusal oral solution vs. triflusal capsules in healthy subjectsA single, randomized, two-way cross-over, open-label phase I study
Arzneimittelforschung·2011· 2 cited
Bioequivalence evaluation of two dosage forms of olanzapine 10 mg formulations in healthy volunteers
Arzneimittelforschung·2011· 8 cited
Bioequivalence evaluation of two strengths of risperidone tablet formulations in healthy volunteers
International Journal of Clinical Pharmacology and Therapeutics·2009· 12 cited

Frequent Co-authors

Mariano Sust(10), Adelaida Morte(10), Anna Vaqué(8), Neus Gascón(5), Carlos R. Plata‐Saláman(5), Oscar A. de León-Casasola(5), Esther Ortiz(5), R. M. Langford(5), Eugene R. Viscusi(4), José María Giménez-Arnau(4), Manuel Cánovas(4), Ferràn Torres(4), Pilar Pelagio(4), Francesc Cabré(4), Sebastián Videla(3), Gregorio Encina(2), Mounia Lahjou(2), Artur Sans(2), Adam Jacobs(2), Ira J. Gottlieb(2)